Anticholinergic action is rarely a good thing

Area of Science:

• Gerontology
• Pharmacology
• Neurology

Background:

• Anticholinergic agents are widely prescribed medications.
• Evidence links these agents to peripheral and central nervous system side effects.
• Recent research highlights associations with dementia and mortality in the elderly.

Purpose of the Study:

• To review the existing evidence on the association between anticholinergic agents and the risk of dementia.
• To examine the link between anticholinergic agent use and increased mortality in individuals with dementia.

Main Methods:

• Literature review of studies published in the last two decades.
• Analysis of evidence regarding anticholinergic effects on cognition and dementia risk.
• Synthesis of data on mortality rates in relation to anticholinergic use in dementia patients.

Main Results:

• Anticholinergic agents are associated with peripheral side effects (e.g., dry mouth, blurred vision, constipation).
• Central effects include cognitive impairment.
• Consistent evidence links anticholinergic use to increased dementia risk and mortality in older populations.

Conclusions:

• Anticholinergic medications pose significant risks, particularly for older adults.
• The association with dementia and increased mortality warrants careful consideration in clinical practice.
• Further research may be needed to elucidate specific mechanisms and identify safer alternatives.